Endovascular optical coherence tomography ex vivo: venous wall anatomy and tissue alterations after endovenous therapy

被引:19
作者
Meissner, Oliver A.
Schmedt, Claus-Georg
Hunger, Kathrin
Hetterich, Holger
Sroka, Ronald
Rieber, Johannes
Babaryka, Gregor
Steckmeier, Bernd Manfred
Reiser, Maximilian
Siebert, Uwe
Mueller-Lisse, Ullrich
机构
[1] Univ Munich, Inst Clin Radiol, D-80336 Munich, Germany
[2] Univ Munich, Dept Vasc Surg & Phlebol, D-80336 Munich, Germany
[3] Univ Munich, Div Cardiol, D-80336 Munich, Germany
[4] Univ Munich, LIFE Ctr, Laser Res Lab, D-80336 Munich, Germany
关键词
optical coherence tomography; endovenous laser therapy; endovenous radio-frequency therapy;
D O I
10.1007/s00330-007-0593-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Endovascular optical coherence tomography (OCT) is a new imaging modality providing histology-like information of the venous wall. Radiofrequency ablation (RFA) and laser therapy (ELT) are accepted alternatives to surgery. This study evaluated OCT for qualitative assessment of venous wall anatomy and tissue alterations after RFA and ELT in bovine venous specimens. One hundred and thirty-four venous segments were obtained from ten ex-vivo bovine hind limbs. OCT signal characteristics for different wall layers were assessed in 180/216 (83%) quadrants from 54 normal venous cross-sections. Kappa statistics (kappa) were used to calculate intra- and inter-observer agreement. Qualitative changes after RFA (VNUS-Closure) and ELT (diode laser 980 nm, energy densities 15 Joules (J)/cm, 25 J/cm, 35 J/cm) were described in 80 venous cross-sections. Normal veins were characterized by a three-layered appearance. After RFA, loss of three-layered appearance and wall thickening at OCT corresponded with circular destruction of tissue structures at histology. Wall defects after ELT ranged from non-transmural punctiform damage to complete perforation, depending on the energy density applied. Intra- and inter-observer agreement for reading OCT images was very high (0.90 and 0.88, respectively). OCT allows for reproducible evaluation of normal venous wall and alterations after endovenous therapy. OCT could prove to be valuable for optimizing endovenous therapy in vivo.
引用
收藏
页码:2384 / 2393
页数:10
相关论文
共 39 条
[1]   Characterizing arterial plaque with optical coherence tomography [J].
Brezinski, M .
CURRENT OPINION IN CARDIOLOGY, 2002, 17 (06) :648-655
[2]   Optical biopsy with optical coherence tomography [J].
Brezinski, ME ;
Tearney, GJ ;
Bouma, B ;
Boppart, SA ;
Pitris, C ;
Southern, JF ;
Fujimoto, JG .
ADVANCES IN OPTICAL BIOPSY AND OPTICAL MAMMOGRAPHY, 1998, 838 :68-74
[3]   Imaging of coronary artery microstructure (in vitro) with optical coherence tomography [J].
Brezinski, ME ;
Tearney, GJ ;
Bouma, BE ;
Boppart, SA ;
Hee, MR ;
Swanson, EA ;
Southern, JF ;
Fujimoto, JG .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (01) :92-93
[4]   The immediate effects of endovenous diode 808-nm laser in the greater saphenous vein: Morphologic study and clinical implications [J].
Corcos, L ;
Dini, S ;
De Anna, D ;
Marangoni, O ;
Ferlaino, E ;
Procacci, T ;
Spina, T ;
Dini, M .
JOURNAL OF VASCULAR SURGERY, 2005, 41 (06) :1018-1024
[5]  
FEIED C, 2005, VARICOSE TREATMENT E
[6]   Optical coherence tomography for ultrahigh resolution in vivo imaging [J].
Fujimoto, JG .
NATURE BIOTECHNOLOGY, 2003, 21 (11) :1361-1367
[7]   High resolution in vivo intra-arterial imaging with optical coherence tomography [J].
Fujimoto, JG ;
Boppart, SA ;
Tearney, GJ ;
Bouma, BE ;
Pitris, C ;
Brezinski, ME .
HEART, 1999, 82 (02) :128-133
[8]   OPTICAL BIOPSY AND IMAGING USING OPTICAL COHERENCE TOMOGRAPHY [J].
FUJIMOTO, JG ;
BREZINSKI, ME ;
TEARNEY, GJ ;
BOPPART, SA ;
BOUMA, B ;
HEE, MR ;
SOUTHERN, JF ;
SWANSON, EA .
NATURE MEDICINE, 1995, 1 (09) :970-972
[9]   Closure of the greater saphenous vein with endoluminal radiofrequency thermal heating of the vein wall in combination with ambulatory phlebectomy: Preliminary 6-month follow-up [J].
Goldman, MP .
DERMATOLOGIC SURGERY, 2000, 26 (05) :452-456
[10]  
Huang SH, 2004, INT J IMMUNOPATH PH, V17, P1